<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: New strategies for delivering <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> follow-up care are needed </plain></SENT>
<SENT sid="1" pm="."><plain>We surveyed primary care providers (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCPs</z:e>) and oncologists to assess how physician attitudes toward and self-efficacy with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> follow-up affect preferences for different <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> survivorship models </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: The survey of physician attitudes regarding the care of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> survivors was mailed to a randomly selected national sample of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCPs</z:e> and oncologists to evaluate their perspectives regarding physician roles, knowledge about survivorship care processes, and views on <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> surveillance </plain></SENT>
<SENT sid="3" pm="."><plain>Multinomial logistic regression models were constructed to examine how physician attitudes towards, and self-efficacy with, their own skills affected preferences for different <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> survivorship care models </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Of 3,434 physicians identified, a total of 2,026 participants provided eligible responses: 938 PCPs and 1,088 oncologists </plain></SENT>
<SENT sid="5" pm="."><plain>Most <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCPs</z:e> (51 %) supported a <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCP</z:e>/shared care model; whereas, the majority of specialists (59 %) strongly endorsed an oncologist-based model (p &lt; 0.001) </plain></SENT>
<SENT sid="6" pm="."><plain>Less than a quarter of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCPs</z:e> and oncologists preferred specialized survivor clinics </plain></SENT>
<SENT sid="7" pm="."><plain>A significant proportion of oncologists (87 %) did not feel that <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCPs</z:e> should take on the primary role of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> follow-up </plain></SENT>
<SENT sid="8" pm="."><plain>Most <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCPs</z:e> believed that they were better able to perform breast and <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> follow-up (57 %), detect <z:e sem="disease" ids="C1458156" disease_type="Neoplastic Process" abbrv="">recurrent cancers</z:e> (74 %), and offer psychosocial support (50 %), but only a minority (32 %) was willing to assume primary responsibility </plain></SENT>
<SENT sid="9" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCPs</z:e> already involved with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> surveillance (43 %) were more likely to prefer a <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCP</z:e>/shared care than oncologist-based survivorship model (OR, 2.08; 95 % CI, 1.34-3.23) </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS AND IMPLICATIONS FOR <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">CANCER</z:e> SURVIVORS: <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCPs</z:e> and oncologists have different preferences for models of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> survivorship care </plain></SENT>
<SENT sid="11" pm="."><plain>Prior involvement with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> surveillance was one of the strongest predictors of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PCPs</z:e>' willingness to assume this responsibility </plain></SENT>
</text></document>